Submit Deal

TANABE PHARMA CORP (MITSUBISHI TANABE PHARMA)

HQ - Osaka

Summary

Tanabe Pharma Corp (previously Mitsubishi Tanabe Pharma America) is a discovery-based pharmaceutical company focused on developing new treatments to improve the lives of patients worldwide.

Deals Overview

Total Deals3

Valued Deals2

Total Value£ 6.15 B

Avg. Deal Size£ 3.07 B

Market Context

Senior Management

Masayuki Mitsuka
CEO
Akihisa Harada
CEO
Akihiro Tsujimura
Representative Director

Sort

18 Nov 2019|Japan|Pharmaceuticals

Target: TANABE PHARMA CORP (MITSUBISHI TANABE PHARMA)

Bidder: MITSUBISHI CHEMICAL HOLDINGS

10 Service Providers

7 Target | 3 Bidder

10 Dealmakers

5 Target | 5 Bidder

£ 3.49 B

Value

07 Feb 2025|Japan|Pharmaceuticals

Target: TANABE PHARMA CORP (MITSUBISHI TANABE PHARMA)

Bidder: BAIN CAPITAL LP

12 Service Providers

1 Target | 10 Bidder | 1 Vendor

35 Dealmakers

1 Target | 33 Bidder | 1 Vendor

£ 2.65 B

Value

22 Dec 2025|United States|Pharmaceuticals

Target: TANABE PHARMA CORP (RADICAVA BUSINESS)

Bidder: SHIONOGI

7 Service Providers

2 Bidder | 5 Vendor

14 Dealmakers

5 Bidder | 9 Vendor

n/a

Value